Roger D. Dansey - Feb 2, 2022 Form 4 Insider Report for Seagen Inc. (SGEN)

Role
Chief Medical Officer
Signature
By: /s/ Jennifer Prosba For: Roger D. Dansey
Stock symbol
SGEN
Transactions as of
Feb 2, 2022
Transactions value $
-$197,378
Form type
4
Date filed
2/4/2022, 04:54 PM
Previous filing
Jan 5, 2022
Next filing
Apr 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SGEN Common Stock Sale -$102K -739 -0.93% $137.58 78.9K Feb 2, 2022 Direct F1, F2
transaction SGEN Common Stock Sale -$95.7K -703 -0.89% $136.14 78.2K Feb 3, 2022 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a 10b5-1 arrangement to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Amount of securities beneficially owned following reported transactions includes restricted stock units subject to vesting and 70 shares acquired under the Amended and Restated 2000 Employee Stock Purchase Plan on January 31, 2022.
F3 The sales reported were effected pursuant to a Rule 10b5-1 plan dated November 11, 2021.